AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Cytarabine in South Africa

13 products registered with SAHPRA — 4 active

Brand / ProductReg. No.HolderStatusExpires
CYTOSAR 1000 mgT/26/48Pfizer Laboratories (Pty) Ltdsuspended28 Sept 2025
CIPLA CYTARABINE INJECTION 100 (5 ml)A39/26/0453Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
CIPLA CYTARABINE INJECTION 100 (10 ml)A39/26/0454Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
CIPLA CYTARABINE INJECTION 100 mg (1 ml)A39/26/0452Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
CYTARABINE-FAULDING 20 mg/ml29/26/0360Pharmaplan (Pty) Ltdsuspended31 May 2024
LARACIT 100 mg37/26/0487Teva Pharmaceuticals (Pty) Ltdsuspended12 Sept 2023
LARACIT 500 mg37/26/0488Teva Pharmaceuticals (Pty) Ltdsuspended12 Sept 2023
ALEXAN 100 mgT/26/83Adcock Ingram Limitedsuspended30 Mar 2022
ALEXAN 500 mgT/26/161Adcock Ingram Limitedsuspended30 Mar 2022
CYTOSAR 500 mgT/26/47Pfizer Laboratories (Pty) Ltdactive1 Jan 1900
CYTARABINE-FAULDING 100 mg/ml29/26/0361Pharmaplan (Pty) Ltdactive1 Jan 1900
P & U CYTARABINE CSV 100 mg/5 ml INJECTION29/26/0499Pfizer Laboratories (Pty) Ltdactive1 Jan 1900
P & U CYTARABINE CSV 500 mg / 25 ml INJECTION30/26/0308Pfizer Laboratories (Pty) Ltdactive1 Jan 1900

Cytarabine — SAHPRA Registration Details

SAHPRA (South Africa) has 13 registered products containing Cytarabine, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Cytarabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.